Mistry, P. K., M. Balwani, H. N. Baris, H. B. Turkia, A. T. Burrow, J. Charrow, G. F. Cox, S. Danda, M. Dragosky, G. Drelichman, et al.,  "Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.",  Blood cells, molecules & diseases, vol. 71, pp. 71-74, 2018.